Skip to main content
. 2021 May 12;40(23):3929–3941. doi: 10.1038/s41388-021-01798-2

Fig. 1. ERK5 expression strongly associates with metastatic occurrence in breast cancer.

Fig. 1

The relationship between the level of ERK5 expression and distant metastasis-free survival of breast cancer (BC) patients was assessed by Kaplan–Meier plotter. Independent cohorts of patients with early (grade 1) or late (grades 2 and 3) stage disease status were analyzed. Samples were divided into two groups with high (red) and low (black) expression of ERK5. Hazard ratios (HR) and logrank P values are shown.